N. Aaronson

Patient-reported depression measures in cancer: a meta-review.

P. Butow, P. Jacobsen, T. Hack, 2015, The lancet. Psychiatry.

A report of the consensus workshop panel on the treatment of brain metastases.

J. Loeffler, L. Coia, T. Priestman, 1992, International journal of radiation oncology, biology, physics.

Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient’s IADL?

M. Taphoorn, J. Reijneveld, S. Sikkes, 2022, Neuro-oncology practice.

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period

R. Stupp, M. J. van den Bent, M. Taphoorn, 2021, Neuro-oncology.

Cancer symptom response as an oncology clinical trial end point

D. Cella, L. Bouchard, N. Aaronson, 2018, Expert review of quality of life in cancer care.

Depressive Symptoms in Danish Patients With Glioma and a Cancer-Free Comparison Group.

B. H. Forchhammer, B. Rasmussen, C. Johansen, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.

Jeffery T. Sloan, P. Hinds, C. Gotay, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period

R. Stupp, M. J. van den Bent, M. Taphoorn, 2022, Neuro-oncology.